Vita Life Sciences Limited VLS
ASX · Avustralya · Sağlık Teknolojisi
AUD 2,74-0,01 (-%0,36)
Piyasa kapalı· · AUD · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Piyasa kapalı· · AUD · Veriler gecikmeli olabilir
Fiyatlar gecikmeli olabilir ve yalnızca bilgilendirme amaçlıdır - yatırım tavsiyesi değildir.
Temettüler dahil toplam getiri.
Fiyatın 50 ve 200 günlük hareketli ortalamalara göre konumu.
Makkler Adil Değer, finansal sağlık skoru, analist görüşü, benzer şirketler ve MakklerAI.
Global bond yields have surged to multi decade highs, which raises funding costs for many companies and keeps share prices choppy. Reliable Australian dividend payers with 5%+ yields can look more attractive when income from bonds and cash improves, but still comes with their own risks. This piece highlights three long running dividend payers from our income screener that may appeal to investors who want consistency and regular cash flow. The stocks highlighted below are just a small sample...
The Australian market is poised for a potential rebound today, with futures indicating a possible one percent increase despite Wall Street's recent lackluster performance. Amidst these fluctuations, investors are increasingly turning their attention to penny stocks—smaller or newer companies that offer growth opportunities at lower price points. Although the term "penny stock" might seem outdated, these investments can still present valuable prospects when backed by robust financial health...
The Australian market is experiencing a mixed performance, with recent fluctuations influenced by global events such as rising oil prices and geopolitical tensions. Despite these challenges, the allure of penny stocks remains strong for investors seeking opportunities in smaller or newer companies. Although the term 'penny stock' might seem outdated, these stocks can offer affordability and growth potential when backed by solid financials.
Üçüncü taraf yayıncıların bu şirket hakkındaki son başlıkları; Makkler'in kendi editoryal içeriğinden ayrı tutulur ve dış kaynağa yönlendirir. Başlıkların doğruluğu ilgili yayıncının sorumluluğundadır.